Literature DB >> 15748940

Role of nociceptin/orphanin FQ (Noc/oFQ) in murine experimental colitis.

Shingo Kato1, Yoshikazu Tsuzuki, Ryota Hokari, Yoshikiyo Okada, Junichi Miyazaki, Koji Matsuzaki, Atsuhiro Iwai, Atsushi Kawaguchi, Shigeaki Nagao, Kazuro Itoh, Hidekazu Suzuki, Toshitaka Nabeshima, Soichiro Miura.   

Abstract

Nociceptin/orphanin (Noc/oFQ), endogenous agonist for nociceptin receptor (NOR), is thought to be a stimulator of neurogenic inflammation. We investigated the possible role of Noc/oFQ in the development of colitis using NOR-deficient mice treated with dextran sulfate sodium (DSS). Colitis was significantly improved in NOR-deficient mice against wild-type mice. Expression level of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) and infiltrating cells also significantly decreased in NOR-deficient mice against wild-type mice. Nociceptin expression increased in wild-type mice after DSS treatment. These results suggest stimulation by Noc/oFQ deteriorates colonic inflammation via up-regulation of adhesion molecule.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15748940     DOI: 10.1016/j.jneuroim.2004.12.006

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  6 in total

1.  Nociceptin/orphanin FQ suppresses adaptive immune responses in vivo and at picomolar levels in vitro.

Authors:  Benito Anton; Phillipe Leff; Joseph J Meissler; Juan C Calva; Rodolfo Acevedo; Alberto Salazar; Maura Matus; Anabel Flores; Martin Martinez; Martin W Adler; John P Gaughan; Toby K Eisenstein
Journal:  J Neuroimmune Pharmacol       Date:  2010-02-02       Impact factor: 4.147

Review 2.  Current overview of opioids in progression of inflammatory bowel disease; pharmacological and clinical considerations.

Authors:  Naser-Aldin Lashgari; Nazanin Momeni Roudsari; Nadia Zandi; Benyamin Pazoki; Atiyeh Rezaei; Mehrnoosh Hashemi; Saeideh Momtaz; Roja Rahimi; Maryam Shayan; Ahmad Reza Dehpour; Amir Hossein Abdolghaffari
Journal:  Mol Biol Rep       Date:  2021-01-04       Impact factor: 2.316

3.  Anti-inflammatory effect of dual nociceptin and opioid receptor agonist, BU08070, in experimental colitis in mice.

Authors:  Marta Zielińska; Tanila Ben Haddou; Gerta Cami-Kobeci; Maciej Sałaga; Agata Jarmuż; Milena Padysz; Radzisław Kordek; Mariana Spetea; Stephen M Husbands; Jakub Fichna
Journal:  Eur J Pharmacol       Date:  2015-09-25       Impact factor: 4.432

Review 4.  Nociceptin system as a target in sepsis?

Authors:  Róisín Thomas; Cordula Stover; David G Lambert; Jonathan P Thompson
Journal:  J Anesth       Date:  2014-04-12       Impact factor: 2.078

5.  NOP Receptor Ligands as Potential Agents for Inflammatory and Autoimmune Diseases.

Authors:  Elaine C Gavioli; Pedro R T Romão
Journal:  J Amino Acids       Date:  2011-11-17

Review 6.  The role of orphanin FQ/nociceptin in neuroplasticity: relationship to stress, anxiety and neuroinflammation.

Authors:  Elyse M Mallimo; Alexander W Kusnecov
Journal:  Front Cell Neurosci       Date:  2013-10-08       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.